![Ixazomib citrate 结构式 Ixazomib citrate 结构式](https://img.biochemsafebuy.com/uploads/company8/20180813/1534154132_hxyxm.png)
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
![](/templates/admin/Portal/site5/assets/images/wxgg.png)
CAS号 | 1239908-20-3 | 货号 | BCP16600 |
中文名 | 枸橼酸艾莎佐米 | ||
英文名 | Ixazomib citrate | ||
中文别名 | 伊莎佐米柠檬酸盐; | ||
英文别名 | MLN9708; MLN-9708; MLN 9708;Ixazomib-prodrug; | ||
SMILES | O=C(O)CC1(CC(O)=O)OB([C@@H](NC(CNC(C2=CC(Cl)=CC=C2Cl)=O)=O)CC(C)C)OC1=O | ||
化学名称 | |||
分子式 | C20H23BCl2N2O9 | 分子量 | 517.119 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | MLN9708, also known as ixazomib citrate, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrolyzing to pharmacologically active MLN2238 (ixazomib), is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity. MLN9708, compared with bortezomib, has improved pharmacokinetics, pharmacodynamics, and antitumor activity in preclinical studies. |
Tags:Ixazomib citrate 供应商,Ixazomib citrate 购买,Ixazomib citrate 生产,Ixazomib citrate 批量,Ixazomib citrate 供应,Ixazomib citrate 订购,Ixazomib citrate 采购